High thoracic low cervical, long-term intrathecal (IT) infusion of bupivacaine alleviates "refractory" pain in patients with unstable angina pectoris: Report of 2 cases

被引:8
|
作者
Dahm, P [1 ]
Nitescu, P [1 ]
Appelgren, L [1 ]
Curelaru, I [1 ]
机构
[1] Gothenburg Univ, Sahlgrens Hosp, Dept Anaesthesia & Intens Care, S-41345 Gothenburg, Sweden
关键词
unstable angina pectoris; thoracic intrathecal analgesia; intrathecal bupivacaine; pain treatment;
D O I
10.1111/j.1399-6576.1998.tb05363.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: There is no reliable treatment for "refractory" pain from unstable angina pectoris (UAP) when epidural infusion of bupivacaine has failed to relieve it. In two such cases we explored the potential of intrathecal (IT) bupivacaine infusion to provide pain relief. Patients and methods: Two female patients, 70 and 67 years. An 18-G nylon catheter was inserted intrathecally through a 17-G Tuohy needle via the T2-T3 interspace and its tip located at the height of C6-C7 vertebrae. The catheter was connected to a portable, programmable electronic pump filled with bupivacaine 5 mg/ml. The infusion started at rates of 0.1-0.2 ml/h, with optional bolus doses of 0.1-0.2 mi 4-2 times/h, respectively, by PCA (Patient-Controlled Analgesia), and then adjusted to give the patients satisfactory (80%-100%) pain relief. Results: Pain relief was obtained with doses of IT-bupivacaine ranging from 17 to 45 (mean=25) mg/d. The pain intensity decreased from VAS (Visual Analogue Score) 9-10 to 0-2 out of 10. The nocturnal sleep improved from 2-4 to 6-7 h. The patients could now ambulate, walking or in a wheel-chair. The IT-treatment lasted 700 and 437 d, of which 540 and 343 d (respectively) were spent at home, and was terminated by: (a) the patient's death due to intracranial bleeding (Ist case); (b) progressive aggravation of the unstable angina that could not be fully countered by increasing the bupivacaine dose above 1.0 mg/h due to occurrence of cerebral transient ischemic attacks, usually not correlated with orthostatic arterial hypotension but apparently facilitated by microembolization of the cerebral arteries (2nd case). Conclusion: IT-bupivacaine infusion may alleviate "refractory" pain in patients with unstable angina pectoris when epidural bupivacaine failed to do so. Its use is apparently Limited by the IT-bupivacaine critical dosage (in these patients=1.0-1.5 mg/h).
引用
收藏
页码:1010 / 1017
页数:8
相关论文
共 25 条
  • [1] Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in long-term treatment of "refractory" nonmalignant pain
    Nitescu, P
    Dahm, P
    Appelgren, L
    Curelaru, I
    CLINICAL JOURNAL OF PAIN, 1998, 14 (01): : 17 - 28
  • [2] LONG-TERM INTRATHECAL INFUSION OF MORPHINE AND MORPHINE BUPIVACAINE MIXTURES IN THE TREATMENT OF CANCER PAIN - A RETROSPECTIVE ANALYSIS OF 51 CASES
    VANDONGEN, RTM
    CRUL, BJP
    DEBOCK, M
    PAIN, 1993, 55 (01) : 119 - 123
  • [3] NEUROPATHOLOGIC FINDINGS AFTER LONG-TERM INTRATHECAL INFUSION OF MORPHINE AND BUPIVACAINE FOR PAIN TREATMENT IN CANCER-PATIENTS
    SJOBERG, M
    KARLSSON, PA
    NORDBORG, C
    WALLGREN, A
    NITESCU, P
    APPELGREN, L
    LINDER, LE
    CURELARU, I
    ANESTHESIOLOGY, 1992, 76 (02) : 173 - 186
  • [4] BACTERIOLOGY, DRUG STABILITY AND EXCHANGE OF PERCUTANEOUS DELIVERY SYSTEMS AND ANTIBACTERIAL FILTERS IN LONG-TERM INTRATHECAL INFUSION OF OPIOID DRUGS AND BUPIVACAINE IN REFRACTORY PAIN
    NITESCU, P
    HULTMAN, E
    APPELGREN, L
    LINDER, LE
    CURELARU, I
    CLINICAL JOURNAL OF PAIN, 1992, 8 (04): : 324 - 337
  • [5] LONG-TERM INTRATHECAL OPIATE + BUPIVACAINE IN PATIENTS WITH ADVANCED CANCER PAIN .2. DOSAGES IN PATIENTS WITH OPIATE-RESISTANT PAIN
    APPELGREN, L
    HULTMAN, E
    LINDER, LE
    NITZESCU, P
    SJOBERG, M
    CURELARU, I
    ANAESTHESIST, 1988, 37 (10): : 121 - 121
  • [6] LONG-TERM INTRATHECAL MORPHINE AND BUPIVACAINE IN PATIENTS WITH REFRACTORY CANCER PAIN - RESULTS FROM A MORPHINE- BUPIVACAINE DOSE REGIMEN OF 0.5/4.75 MG/ML
    SJOBERG, M
    NITESCU, P
    APPELGREN, L
    CURELARU, L
    ANESTHESIOLOGY, 1994, 80 (02) : 284 - 297
  • [7] LONG-TERM INTRATHECAL MORPHINE AND BUPIVACAINE IN REFRACTORY CANCER PAIN .1. RESULTS FROM THE 1ST SERIES OF 52 PATIENTS
    SJOBERG, M
    APPELGREN, L
    EINARSSON, S
    HULTMAN, E
    LINDER, LE
    NITESCU, P
    CURELARU, I
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1991, 35 (01) : 30 - 43
  • [8] PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS REFRACTORY TO MEDICAL THERAPY - LONG-TERM CLINICAL AND ANGIOGRAPHIC RESULTS
    PLOKKER, HWT
    ERNST, SMPG
    BAL, ET
    VANDENBERG, ECJM
    MAST, GEG
    VANDERFELTZ, TA
    ASCOOP, CAPL
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1988, 14 (01): : 15 - 18
  • [9] PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY (PTCA) IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS REFRACTORY TO MEDICAL THERAPY - LONG-TERM CLINICAL AND ANGIOGRAPHIC RESULTS
    PLOKKER, HWT
    ERNST, JMPG
    VERMEULEN, FEE
    BAL, ET
    ASCOOP, CAPL
    CIRCULATION, 1986, 74 (04) : 283 - 283
  • [10] Ten years positive experience of long-term home self-treatment with thoracic epidural analgesia in patients with refractory angina pectoris: effects on angina, quality of life and exercise test
    Richter, A. J.
    Cederholm, I.
    Fredrikson, M.
    Wodlin, P.
    Gjerde, M.
    Mucchiano, C.
    Sjoberg, B. Janerot
    EUROPEAN HEART JOURNAL, 2009, 30 : 453 - 453